Page last updated: 2024-11-06

floxuridine and Lung Diseases

floxuridine has been researched along with Lung Diseases in 2 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Lung Diseases: Pathological processes involving any part of the LUNG.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, SI1
Kim, HJ1
Skubitz, KM1
Chabner, BA1
Myers, CE1
Coleman, CN1
Johns, DG1

Reviews

1 review available for floxuridine and Lung Diseases

ArticleYear
The clinical pharmacology of antineoplastic agents (first of two parts).
    The New England journal of medicine, 1975, May-22, Volume: 292, Issue:21

    Topics: Animals; Antineoplastic Agents; Asparaginase; Binding Sites; Biological Transport; Chemical and Drug

1975

Other Studies

1 other study available for floxuridine and Lung Diseases

ArticleYear
Pulmonary toxicity of continuous infusion 5-fluoro-2'-deoxyuridine.
    Anti-cancer drugs, 1995, Volume: 6, Issue:3

    Topics: Aged; Carcinoma, Renal Cell; Floxuridine; Humans; Infusions, Intravenous; Kidney Neoplasms; Lung Dis

1995